Donanemab for Alzheimer Disease, Sugary Drinks and Liver Disease, Cervical Cancer Screening, and more
Release Date:
Editor’s Summary by Anne Rentoumis Cappola, MD, ScM, Associate Editor of JAMA, the Journal of the American Medical Association, for the August 8, 2023, issue.
Donanemab for Alzheimer Disease, Sugary Drinks and Liver Disease, Cervical Cancer Screening, and more